Clinical Trials
2 trialsNCT03556228 2025-12-11
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
VM Oncology, LLC
Phase 1/2 Recruiting
NCT06051747 2023-09-25
Patient-Customized Bioprinting Technology for Practical Regeneration of the Respiratory Tract (Trachea)
Seoul St. Mary's Hospital
Phase 1/2 Unknown